Deval P Gadhvi MD

Deval P Gadhvi MD operates a primary care practice in Jersey City, New Jersey, offering comprehensive medical services that span preventative care, chronic disease management, and specialized weight management programs utilizing GLP-1 receptor agonist peptides. Dr. Gadhvi provides both in-person consultations at the Jersey City location and telehealth appointments for patients throughout New Jersey, addressing the diverse healthcare needs of the local community including LGBTQIA+ patients, travelers requiring pre-trip consultations and vaccinations, and individuals seeking USCIS medical examinations for immigration purposes. The practice functions as a full-service primary care clinic where patients establish ongoing relationships for routine health maintenance alongside targeted therapeutic interventions.

Deval P Gadhvi MD's peptide therapy menu includes Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.

Dr. Deval P Gadhvi brings primary care expertise to his Jersey City practice, managing the full spectrum of adult medicine from acute illness treatment to complex chronic conditions including diabetes, hypertension, and metabolic syndrome. His approach to sexual health encompasses evaluation and treatment of erectile dysfunction, low testosterone, and related hormonal concerns, with peptide therapies integrated where clinically appropriate. The practice maintains specific competency in LGBTQIA+ healthcare, addressing the unique preventative and therapeutic needs of gender-diverse and sexual minority patients including hormone therapy monitoring, PrEP prescribing for HIV prevention, and culturally competent screening protocols. For patients requiring travel medicine services, Dr. Gadhvi provides destination-specific vaccine recommendations, malaria prophylaxis prescriptions, and pre-travel health consultations. The clinic also serves as a designated civil surgeon for USCIS medical examinations, completing Form I-693 documentation for immigration and adjustment of status applications.

Patients scheduling appointments with Deval P Gadhvi MD can expect a structured intake process that includes completion of health history forms, often via digital platforms like iPad-based systems for streamlined data collection. New patient visits typically involve comprehensive physical examination, review of previous medical records, and discussion of current health concerns and treatment goals. For weight management consultations specifically, patients undergo baseline measurements including weight, blood pressure, and laboratory testing to establish eligibility for semaglutide or tirzepatide therapy. The practice accepts various insurance plans, though patients should verify coverage specifics for peptide medications as formulary inclusion and prior authorization requirements vary significantly between carriers. Follow-up protocols for peptide therapy patients generally include monthly check-ins during the titration phase, with visit frequency adjusted based on individual progress and side effect profiles. The Jersey City office provides both scheduled appointments and accommodates urgent care needs for established patients.

Deval P Gadhvi MD differentiates itself through the integration of advanced peptide therapeutics within a traditional primary care framework, allowing patients to access emerging weight management treatments without fragmenting their healthcare across multiple providers. The hybrid care model—offering both face-to-face visits at the Jersey City location and remote telehealth consultations—provides flexibility for patients with scheduling constraints or those managing chronic conditions requiring frequent touchpoints. The practice's commitment to serving diverse populations, including explicit focus on LGBTQIA+ health and immigrant communities requiring USCIS examinations, positions it as an inclusive healthcare resource in the Jersey City area. Patients benefit from continuity of care where their primary care physician maintains oversight of peptide therapy alongside management of comorbid conditions, medication interactions, and preventative health measures, creating a coordinated approach to metabolic health and overall wellness.